Faster global financial news!
Amylyx Pharmaceuticals (AMLX) early trading gains extended to 54% after its experimental drug met the primary endpoint in a late-stage trial.
svmuu.com18/08/2026 11:19
Complaint Report
Complaint Report
Amylyx Pharmaceuticals' experimental drug successfully met its primary endpoint in a late-stage trial for patients experiencing hypoglycemia after weight-loss surgery.
Source：彭博市场 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: KKR reportedly offers $9 billion, or $42.50 per share, to acquire natural gas and electricity distributor UGI
|
Next: Bloomberg strategist Simon White warns that the "ultra-low correlation" in US stocks faces a risk of severe shocks, and anomalous gamma fluctuations could become the "switch" for market volatility.
24H Trending
-
1
What is Mantle (MNT)? An Analysis of Its Ecosystem and Market Performance
-
2
NIOX Coin (Autonio) Project Analysis: Positioning, Current Status, and Future Development Prospects
-
3
PancakeSwap (CAKE) Investment Risks and Opportunities Analysis
-
4
ETHY (Ethy AI) Token Analysis: On-chain Identity and AI Agents, Trading Channels and Market Status
-
5
LILFLOKI Token Analysis: Project Positioning, Current Status, and Investment Risk Assessment
-
6
AADA Coin Analysis: Aada Finance's Cardano Lending Protocol and Future Development
-
7
Bitcoin ETFs saw nearly $390 million in net outflows last week, sparking market concern over cautious institutional investor sentiment.
-
8
CKUSD Stablecoin Project Status Analysis: Market Activity and Investment Risks
-
9
KRED Coin Analysis: The Current State and Future Prospects of the Gaming Token in the JEDSTAR Ecosystem
-
10
FXT Coin Analysis: Distinguishing FXT Token from FTX Token (FTT) and Their Market Status
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
